298 related articles for article (PubMed ID: 24305567)
1. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes.
Katsuki S; Matoba T; Nakashiro S; Sato K; Koga J; Nakano K; Nakano Y; Egusa S; Sunagawa K; Egashira K
Circulation; 2014 Feb; 129(8):896-906. PubMed ID: 24305567
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
3. Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe.
Sato K; Nakano K; Katsuki S; Matoba T; Osada K; Sawamura T; Sunagawa K; Egashira K
J Atheroscler Thromb; 2012; 19(11):986-98. PubMed ID: 22785139
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe
Katsuki S; Koga JI; Matoba T; Umezu R; Nakashiro S; Nakano K; Tsutsui H; Egashira K
J Atheroscler Thromb; 2022 Jan; 29(1):111-125. PubMed ID: 33455994
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
[TBL] [Abstract][Full Text] [Related]
6. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
8. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
10. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
11. StemBell therapy stabilizes atherosclerotic plaques after myocardial infarction.
Woudstra L; Meinster E; VAN Haren L; Kay AM; Koopman M; Belien JAM; Morrison MC; VAN Rossum AC; Helder MN; Juffermans LJM; Niessen HWM; Krijnen PAJ
Cytotherapy; 2018 Sep; 20(9):1143-1154. PubMed ID: 30107976
[TBL] [Abstract][Full Text] [Related]
12. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
Chen H; Yang J; Zhang Q; Chen LH; Wang Q
Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.
Ikeda G; Matoba T; Ishikita A; Nagaoka K; Nakano K; Koga JI; Tsutsui H; Egashira K
J Am Heart Assoc; 2021 Jun; 10(12):e019521. PubMed ID: 34056918
[TBL] [Abstract][Full Text] [Related]
14. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.
Ni W; Egashira K; Kitamoto S; Kataoka C; Koyanagi M; Inoue S; Imaizumi K; Akiyama C; Nishida KI; Takeshita A
Circulation; 2001 Apr; 103(16):2096-101. PubMed ID: 11319201
[TBL] [Abstract][Full Text] [Related]
15. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
[TBL] [Abstract][Full Text] [Related]
16. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C
Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753
[TBL] [Abstract][Full Text] [Related]
17. Carbon Monoxide Impairs CD11b
Wu J; Zhang R; Hu G; Zhu HH; Gao WQ; Xue J
J Immunol; 2018 Mar; 200(6):2104-2114. PubMed ID: 29440506
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.
Nie P; Li D; Hu L; Jin S; Yu Y; Cai Z; Shao Q; Shen J; Yi J; Xiao H; Shen L; He B
PLoS One; 2014; 9(5):e97009. PubMed ID: 24816562
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I.
Reimers GJ; Jackson CL; Rickards J; Chan PY; Cohn JS; Rye KA; Barter PJ; Rodgers KJ
Cardiovasc Res; 2011 Jul; 91(1):37-44. PubMed ID: 21354994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
